Search
for
Sort by
Research 691–720 of 1000+
- Biomarker development for PCOS diagnosis
- Treatment of Chemotherapy Induced Alopecia
- Prevention of chemotherapy drug-mediated human hair follicle damage: combined use of cooling with antioxidant suppresses oxidative stress and prevents matrix keratinocyte cytotoxicity
- Anabolic androgenic steroids and carcinogenicity focusing on Leydig cell: a literature review
- Bioengineered Plants Can Be a Useful Source of Omega-3 Fatty Acids
- POLYCYSTIC OVARY SYNDROME (PCOS): DIAGNOSIS, PATHOPHYSIOLOGY AND CONTEMPORARY THERAPEUTIC APPROACHES
- Fundamental Concepts and Novel Aspects of Polycystic Ovarian Syndrome: Expert Consensus Resolutions
- COVID-19 pandemic: what about the gonads?
- POLYCYSTIC OVARY SYNDROME: PATHOGENESIS, TREATMENT AND SECONDARY ASSOCIATED DISEASES
- Pathophysiology and Nutritional Approaches in Polycystic Ovary Syndrome (PCOS): A Comprehensive Review
- Impact of Reducing Obesity in PCOS: Methods and Treatment Outcomes
- Hirsutism-A Comprehensive Update of Embryology, Aetiopathogenesis and Therapeutic Approach
- Polycystic Ovary Syndrome: Explaining the Gynecological Aspects and Treatment Options to Patients
- Serological Diagnosis of Helicobacter pylori Infection in Patients With a Polycystic Ovary Syndrome
- Systemic Lupus Erythematosus: What Every Clinician Needs to Know
- Understanding Polycystic Ovary Syndrome: A Comprehensive Guide
- A different approach to PCOS: evaluation of spermiogram results in male patients with a family history of PCOS
- Bicalutamide: A review
- When one size does not fit all: Reconsidering PCOS etiology, diagnosis, clinical subgroups, and subgroup-specific treatments
- Women With Polycystic Ovary Syndrome: A Review of Susceptibility to Type 2 Diabetes
- Polycystic ovary syndrome: Diagnosis and management
- Real-world safety of Tepotinib: Insights from the Food and Drug Administration Adverse Event Reporting System
- Circulating androgen regulation by androgen-catabolizing gut bacteria in male mouse gut
- 5116 Postmenopausal Hyperandrogenism due to Rare Ovarian Tumor
- 9243 Postmenopausal Hyperandrogenism due to Rare Ovarian Tumor
- 9243 Postmenopausal Hyperandrogenism due to Rare Ovarian Tumor
- Angiogenesis: a Dynamic Balance of Stimulators and Inhibitors
- Breast implant illness: a topic in review
- Ovary and uterus related adverse events associated with statin use: an analysis of the FDA Adverse Event Reporting System
- Selenium: When a good nutrient goes bad